Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
The proposed shift of marijuana to a Schedule III drug highlights its recognized medical applications and potential to treat conditions like anxiety and chronic pain, offering a safer alternative to traditional treatments.
Family Medicine/General Practice May 14th 2024
Healthline
Explore the complexities of cannabis withdrawal, including its symptoms, management strategies, and the role of healthcare providers in supporting patients through this transition.
Family Medicine/General Practice March 5th 2024
Physicians must comprehend the detection windows for THC and its metabolites, crucial for advising patients on cannabis use and interpreting drug test results. Factors such as dosage, frequency, and method of consumption directly impact THC’s longevity in the system.
All Specialties February 6th 2024
The Epoch Times
Cannabis use may induce alterations in DNA methylation, potentially leading to serious health conditions and transgenerational impacts, as revealed in a recent study.
Family Medicine/General Practice January 8th 2024
Johns Hopkins Medicine
Johns Hopkins University is conducting a comprehensive study on the therapeutic use of cannabis, aiming to provide insights into its efficacy and health impacts.
Internal Medicine January 3rd 2024
The New England Journal of Medicine
This review provides a deep dive into the complexities of cannabis use disorder, highlighting the urgent need for further research and effective treatments.
Family Medicine/General Practice January 3rd 2024